{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T03:17:44Z","timestamp":1776050264136,"version":"3.50.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,5]],"date-time":"2020-09-05T00:00:00Z","timestamp":1599264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,5]],"date-time":"2020-09-05T00:00:00Z","timestamp":1599264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cerebellum"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s12311-020-01185-9","type":"journal-article","created":{"date-parts":[[2020,9,5]],"date-time":"2020-09-05T02:02:31Z","timestamp":1599271351000},"page":"134-139","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Progressive Ataxia with Hemiplegic Migraines: a Phenotype of CACNA1A Missense Mutations, Not CAG Repeat Expansions"],"prefix":"10.1007","volume":"20","author":[{"given":"Kevin R.","family":"Duque","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6438-9911","authenticated-orcid":false,"given":"Luca","family":"Marsili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Sturchio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhimanyu","family":"Mahajan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aristide","family":"Merola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto J.","family":"Espay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcelo A.","family":"Kauffman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,5]]},"reference":[{"key":"1185_CR1","volume-title":"Hereditary Ataxia Overview. 1998 Oct 28 [Updated 2019 Jul 25]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews\u00ae [Internet]","author":"TD Bird","year":"1993","unstructured":"Bird TD. Hereditary Ataxia Overview. 1998 Oct 28 [Updated 2019 Jul 25]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews\u00ae [Internet]. Seattle (WA): University of Washington, Seattle; 1993. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1138\/"},{"key":"1185_CR2","first-page":"1","volume":"38","author":"Headache Classification Committee of the International Headache Society (IHS)","year":"2018","unstructured":"Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38:1\u2013211.","journal-title":"Cephalalgia"},{"key":"1185_CR3","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/nrneurol.2011.228","volume":"8","author":"S Rajakulendran","year":"2012","unstructured":"Rajakulendran S, Kaski D, Hanna MG. Neuronal P\/Q-type calcium channel dysfunction in inherited disorders of the CNS. Nat Rev Neurol. 2012;8:86\u201396.","journal-title":"Nat Rev Neurol"},{"key":"1185_CR4","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1177\/0333102414532379","volume":"35","author":"CM Weller","year":"2015","unstructured":"Weller CM, Leen WG, Neville BG, Duncan JS, de Vries B, Geilenkirchen MA, et al. A novel SLC2A1 mutation linking hemiplegic migraine with alternating hemiplegia of childhood. Cephalalgia. 2015;35:10\u20135.","journal-title":"Cephalalgia."},{"key":"1185_CR5","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1002\/mds.25706","volume":"29","author":"L Rochester","year":"2014","unstructured":"Rochester L, Galna B, Lord S, Mhiripiri D, Eglon G, Chinnery PF. Gait impairment precedes clinical symptoms in spinocerebellar ataxia type 6: gait ataxia precedes clinical symptoms in SCA6. Mov Disord. 2014;29:252\u20135.","journal-title":"Mov Disord"},{"key":"1185_CR6","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.gaitpost.2017.11.024","volume":"60","author":"E Buckley","year":"2018","unstructured":"Buckley E, Mazz\u00e0 C, McNeill A. A systematic review of the gait characteristics associated with cerebellar ataxia. Gait Posture. 2018;60:154\u201363.","journal-title":"Gait Posture"},{"key":"1185_CR7","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.gaitpost.2009.10.014","volume":"31","author":"KK Patterson","year":"2010","unstructured":"Patterson KK, Gage WH, Brooks D, Black SE, McIlroy WE. Evaluation of gait symmetry after stroke: a comparison of current methods and recommendations for standardization. Gait Posture. 2010;31:241\u20136.","journal-title":"Gait Posture"},{"key":"1185_CR8","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41572-019-0074-3","volume":"5","author":"T Klockgether","year":"2019","unstructured":"Klockgether T, Mariotti C, Paulson HL. Spinocerebellar ataxia. Nat Rev Dis Primers. 2019;5:24.","journal-title":"Nat Rev Dis Primers"},{"key":"1185_CR9","unstructured":"Casey HL, Gomez CM. Spinocerebellar ataxia type 6. 1998 Oct 23 [Updated 2019 Nov 21]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews\u00ae [Internet]. Seattle (WA): University of Washington, Seattle; 1993. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1140\/"},{"key":"1185_CR10","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1212\/01.wnl.0000325057.33666.72","volume":"71","author":"T Schmitz-Hubsch","year":"2008","unstructured":"Schmitz-Hubsch T, Coudert M, Bauer P, Giunti P, Globas C, Baliko L, et al. Spinocerebellar ataxia types 1, 2, 3, and 6: disease severity and nonataxia symptoms. Neurology. 2008;71:982\u20139.","journal-title":"Neurology."},{"key":"1185_CR11","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/S1474-4422(11)70048-5","volume":"10","author":"MB Russell","year":"2011","unstructured":"Russell MB, Ducros A. Sporadic and familial hemiplegic migraine: pathophysiological mechanisms, clinical characteristics, diagnosis, and management. Lancet Neurol. 2011;10:457\u201370.","journal-title":"Lancet Neurol"},{"key":"1185_CR12","doi-asserted-by":"publisher","first-page":"5755","DOI":"10.1523\/JNEUROSCI.5346-10.2011","volume":"31","author":"K Eikermann-Haerter","year":"2011","unstructured":"Eikermann-Haerter K, Yuzawa I, Qin T, Wang Y, Baek K, Kim YR, et al. Enhanced subcortical spreading depression in familial hemiplegic migraine type 1 mutant mice. J Neurosci. 2011;31:5755\u201363.","journal-title":"J Neurosci"},{"key":"1185_CR13","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/s12311-009-0117-5","volume":"8","author":"JJ Plomp","year":"2009","unstructured":"Plomp JJ, van den Maagdenberg AMJM, Kaja S. The ataxic Cacna1a-mutant mouse rolling Nagoya: an overview of neuromorphological and electrophysiological findings. Cerebellum. 2009;8:222\u201330.","journal-title":"Cerebellum."},{"key":"1185_CR14","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1002\/ana.21815","volume":"67","author":"AMJM van den Maagdenberg","year":"2010","unstructured":"van den Maagdenberg AMJM, Pizzorusso T, Kaja S, Terpolilli N, Shapovalova M, Hoebeek FE, et al. High cortical spreading depression susceptibility and migraine-associated symptoms in Ca v 2.1 S218L mice. Ann Neurol. 2010;67:85\u201398.","journal-title":"Ann Neurol"},{"key":"1185_CR15","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1007\/s12311-010-0236-z","volume":"10","author":"F Foti","year":"2011","unstructured":"Foti F, Laricchiuta D, Cutuli D, De Bartolo P, Gelfo F, Angelucci F, et al. Exposure to an enriched environment accelerates recovery from cerebellar lesion. Cerebellum. 2011;10:104\u201319.","journal-title":"Cerebellum."}],"container-title":["The Cerebellum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12311-020-01185-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12311-020-01185-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12311-020-01185-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,5]],"date-time":"2021-09-05T00:12:20Z","timestamp":1630800740000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12311-020-01185-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,5]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["1185"],"URL":"https:\/\/doi.org\/10.1007\/s12311-020-01185-9","relation":{},"ISSN":["1473-4222","1473-4230"],"issn-type":[{"value":"1473-4222","type":"print"},{"value":"1473-4230","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,5]]},"assertion":[{"value":"27 August 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest related to the research covered in this article. Aristide Merola is supported by NIH (KL2 TR001426) and has received speaker honoraria from CSL Behring, Cynapsus Therapeutics, Lundbeck, AbbVie, and Abbott. He has received grant support from Lundbeck and Abbott. Alberto J. Espay has received grant support from the NIH and the Michael J Fox Foundation; personal compensation as a consultant\/scientific advisory board member for AbbVie, Neuroderm, Neurocrine, Amneal, Adamas, Acadia, Acorda, InTrance, Sunovion, Lundbeck, and US WorldMeds; publishing royalties from Lippincott Williams & Wilkins, Cambridge University Press, and Springer; and honoraria from US WorldMeds, Acadia, and Sunovion. Marcelo A. Kauffman is an employee of the CONICET and has received grant support from the Ministry of Science and Technology of Argentina and the Ministry of Health of Buenos Aires.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The clinical assessment and genetic testing on the patient were part of the study #2017-5985 approved by the Human Research Ethics committee of the University of Cincinnati. The procedures used in this study adhere to the tenets of the 1964 Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Written informed consent was obtained from the participant included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"The authors affirm that the participant provided informed consent for publication of the images and videos.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Publish"}}]}}